Search company, investor...

Predict your next investment

BioGeneration Ventures company logo
Venture Capital
biogenerationventures.com

Investments

69

Portfolio Exits

8

Funds

6

Partners & Customers

5

About BioGeneration Ventures

BioGeneration Ventures is a venture capital firm specializing in seed investment for innovative early-stage life sciences companies. It invests in the life sciences, medical, and healthcare sectors. The company was founded in 2006 and is based in Naarden, Netherlands.

Headquarters Location

Gooimeer 2-35

Naarden, 1411 DC,

Netherlands

+31 (0) 35 699 30 00

Are you an investor?
Submit your portfolio details now to be considered in our investor rankings.

Latest BioGeneration Ventures News

The Netherlands: Kelly joins BGV as analyst

Nov 14, 2023

Domhnall Kelly has joined medical and healthcare investor BioGeneration Ventures (BGV) as an analyst. Prior to joining BGV, Domhnall, who was awarded his PhD in Tissue Engineering from the Royal College of Surgeons in Ireland (RCSI), funded by the Irish Research Council, was a fellow within the Life Science investment team at Bioqube Ventures in […]

BioGeneration Ventures Investments

69 Investments

BioGeneration Ventures has made 69 investments. Their latest investment was in VectoryTx Therapeutics as part of their Series A on November 11, 2023.

CBI Logo

BioGeneration Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

11/13/2023

Series A

VectoryTx Therapeutics

$137.85M

No

2

10/17/2023

Seed VC

Tessellate BIO

$8.45M

Yes

3

9/13/2023

Series A - II

Mironid

Yes

1

7/5/2023

Seed VC - II

Subscribe to see more

$99M

Subscribe to see more

10

5/25/2023

Series B - II

Subscribe to see more

$99M

Subscribe to see more

10

Date

11/13/2023

10/17/2023

9/13/2023

7/5/2023

5/25/2023

Round

Series A

Seed VC

Series A - II

Seed VC - II

Series B - II

Company

VectoryTx Therapeutics

Tessellate BIO

Mironid

Subscribe to see more

Subscribe to see more

Amount

$137.85M

$8.45M

$99M

$99M

New?

No

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

3

1

10

10

BioGeneration Ventures Portfolio Exits

8 Portfolio Exits

BioGeneration Ventures has 8 portfolio exits. Their latest portfolio exit was SynAffix on June 01, 2023.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

6/1/2023

Acquired

$99M

8

8/1/2022

Corporate Majority

Subscribe to see more

$99M

Subscribe to see more

10

12/17/2015

Corporate Majority

Subscribe to see more

$99M

Subscribe to see more

10

9/16/2015

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

9/15/2015

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/1/2023

8/1/2022

12/17/2015

9/16/2015

9/15/2015

Exit

Acquired

Corporate Majority

Corporate Majority

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

8

10

10

10

10

BioGeneration Ventures Fund History

6 Fund Histories

BioGeneration Ventures has 6 funds, including BioGeneration Ventures Fund V.

Closing Date

Fund

Fund Type

Status

Amount

Sources

7/13/2023

BioGeneration Ventures Fund V

$167.06M

1

1/7/2021

BioGeneration Ventures Fund IV

$99M

10

7/9/2018

BioGeneration Ventures Fund III

$99M

10

10/31/2017

BioGeneration Ventures III

Subscribe to see more

Subscribe to see more

$99M

10

12/31/2012

BioGeneration Ventures II

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

7/13/2023

1/7/2021

7/9/2018

10/31/2017

12/31/2012

Fund

BioGeneration Ventures Fund V

BioGeneration Ventures Fund IV

BioGeneration Ventures Fund III

BioGeneration Ventures III

BioGeneration Ventures II

Fund Type

Subscribe to see more

Subscribe to see more

Status

Subscribe to see more

Subscribe to see more

Amount

$167.06M

$99M

$99M

$99M

$99M

Sources

1

10

10

10

10

BioGeneration Ventures Partners & Customers

5 Partners and customers

BioGeneration Ventures has 5 strategic partners and customers. BioGeneration Ventures recently partnered with Forbion on October 10, 2023.

Date

Type

Business Partner

Country

News Snippet

Sources

10/17/2023

Partner

Netherlands

Tessellate BIO Emerges from Stealth

Forbion operates a joint venture with BioGeneration Ventures , the manager of seed and early-stage funds , especially focused on Benelux and Germany .

1

1/18/2022

Partner

Switzerland

Subscribe to see more

Subscribe to see more

10

12/14/2020

Vendor, and Client

Switzerland, and Netherlands

Subscribe to see more

Subscribe to see more

10

12/10/2020

Partner

Netherlands

Subscribe to see more

Subscribe to see more

10

7/21/2020

Partner

Denmark

Subscribe to see more

Subscribe to see more

10

Date

10/17/2023

1/18/2022

12/14/2020

12/10/2020

7/21/2020

Type

Partner

Partner

Vendor, and Client

Partner

Partner

Business Partner

Country

Netherlands

Switzerland

Switzerland, and Netherlands

Netherlands

Denmark

News Snippet

Tessellate BIO Emerges from Stealth

Forbion operates a joint venture with BioGeneration Ventures , the manager of seed and early-stage funds , especially focused on Benelux and Germany .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

10

10

BioGeneration Ventures Team

2 Team Members

BioGeneration Ventures has 2 team members, including current Founder, Managing Partner, Edward van Wezel.

Name

Work History

Title

Status

Edward van Wezel

Founder, Managing Partner

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Edward van Wezel

Subscribe to see more

Work History

Title

Founder, Managing Partner

Subscribe to see more

Status

Current

Subscribe to see more

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.